Health and Healthcare
Major Pharma Short Interest Surges
Published:
Last Updated:
Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study come back negative or a candidate not be approved. Conversely, if a drug gains FDA approval or passes a clinical trial, there can be big upside.
The Trump administration has promised reforms in the health care sector, such as changing the bidding process for drugs and shortening the FDA approval process. It has yet to be seen how much headway the White House can actually make with these reforms, even after the House of Representatives vote on Trump’s repeal of Obamacare.
Keep in mind that short sellers betting against big pharma are taking on an added risk. They have to pay out the ongoing high dividends on top of the cost of borrowing the shares.
The May 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly upward.
Short interest in Pfizer Inc. (NYSE: PFE) increased to 46.88 million shares from the previous 47.33 million. Its shares were last seen at $32.05, within a 52-week trading range of $29.83 to $37.39.
The number of Merck & Co. Inc. (NYSE: MRK) shares short jumped to 18.46 million from 15.07 million in the previous period. Its shares were trading at $64.93, in a 52-week range of $55.10 to $66.80.
Teva Pharmaceutical Industries Ltd.’s (NYSE: TEVA) short interest was not updated for this period. The previous level was 22.63 million. Shares were trading at $28.98, in a 52-week range of $28.06 to $56.46.
Bristol-Myers Squibb Co. (NYSE: BMY) short interest increased to 19.23 million shares, from the previous reading of 18.41 million. Shares were trading at $53.82, within a 52-week range of $46.01 to $77.12.
The number of shares short in AbbVie Inc. (NYSE: ABBV) decreased to 30.33 million, compared to the previous 32.65 million. The stock was trading at $65.93, in a 52-week range of $55.06 to $68.12.
Eli Lilly and Co.’s (NYSE: LLY) short interest decreased slightly to 10.03 million shares from the previous 10.76 million. The stock was trading at $77.96. The 52-week range is $64.18 to $86.72.
Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored)
Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.
Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.
Click here now to get started.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
